Back to Search Start Over

Human influenza a virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death

Authors :
Ana Falcón
Celia Gutierrez
Guadalupe Guerrero-Serna
Sami F. Noujaim
Christopher Pablo Cop
Noelia Zamarreño
José Ángel Nicolás-Ávila
José Jalife
Manuel Desco
Alejandro Bernabe
Andrés Hidalgo
Daniela Ponce-Balbuena
Jesús Ruiz-Cabello
David Filgueiras-Rama
Jasmina Vasilijevic
Amelia Nieto
Jose Manuel Alfonso
Daniel Calle
Fundación La Caixa
European Molecular Biology Organization
Ministerio de Ciencia, Innovación y Universidades (España)
Centro de Investigación Biomedica en Red - CIBER
Fundación ProCNIC
Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
Frankel Cardiovascular Centre, Michigan Medicine (Estados Unidos)
NIH - National Heart, Lung, and Blood Institute (NHLBI) (Estados Unidos)
Source :
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid, instname, Cardiovasc Res, Repisalud, Instituto de Salud Carlos III (ISCIII)
Publication Year :
2021
Publisher :
Cambridge University Prees, 2021.

Abstract

Human influenza A virus (hIAV) infection is associated with important cardiovascular complications, although cardiac infection pathophysiology is poorly understood. We aimed to study the ability of hIAV of different pathogenicity to infect the mouse heart, and establish the relationship between the infective capacity and the associated in vivo, cellular and molecular alterations. We evaluated lung and heart viral titres in mice infected with either one of several hIAV strains inoculated intranasally. 3D reconstructions of infected cardiac tissue were used to identify viral proteins inside mouse cardiomyocytes, Purkinje cells, and cardiac vessels. Viral replication was measured in mouse cultured cardiomyocytes. Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) were used to confirm infection and study underlying molecular alterations associated with the in vivo electrophysiological phenotype. Pathogenic and attenuated hIAV strains infected and replicated in cardiomyocytes, Purkinje cells, and hiPSC-CMs. The infection was also present in cardiac endothelial cells. Remarkably, lung viral titres did not statistically correlate with viral titres in the mouse heart. The highly pathogenic human recombinant virus PAmut showed faster replication, higher level of inflammatory cytokines in cardiac tissue and higher viral titres in cardiac HL-1 mouse cells and hiPSC-CMs compared with PB2mut-attenuated virus. Correspondingly, cardiac conduction alterations were especially pronounced in PAmut-infected mice, associated with high mortality rates, compared with PB2mut-infected animals. Consistently, connexin43 and NaV1.5 expression decreased acutely in hiPSC-CMs infected with PAmut virus. YEM1L protease also decreased more rapidly and to lower levels in PAmut-infected hiPSC-CMs compared with PB2mut-infected cells, consistent with mitochondrial dysfunction. Human IAV infection did not increase myocardial fibrosis at 4-day post-infection, although PAmut-infected mice showed an early increase in mRNAs expression of lysyl oxidase. Human IAV can infect the heart and cardiac-specific conduction system, which may contribute to cardiac complications and premature death. JV is a PhD fellow of the La Caixa Foundation International Fellowship Programme (La Caixa/CNB). This work was supported by the European Molecular Biology Organizat ion (STF-7649 to AF), the Spanish Ministry of Science, Innovation and Universities (MCIU), (BFU2011-26175 and BFU2014-57797-R to AN), and the network Ciber de Enfermedades Respiratorias (CIBERES) including the Improvement and Mobilit y Programme. The CNIC is a Severo Ochoa Center of Excellence (SEV-2015-0505). CNIC is supported by MCIU and the Pro CNIC Foundation. This study was supported by grants from Fondo Europeo de Desarrollo Regional (CB16/11/00458), grants SAF2015-65607-R and SAF2016-80324-R from MCIU (A.H. and D.F-R.) and fellowship SVP-2014-068595 to J.A.N-A. This study was supported by Frankel Cardiovascular Centre, Michigan Medicine (Grant 332475). JJ is supported in part by the National Heart, Lung, and Blood Institute (R01 Grant HL122352). S.F.N is supported in part by the National Heart, Lung, and Blood Institute grants R21HL138064 and R01HL129136. Sí

Details

Database :
OpenAIRE
Journal :
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid, instname, Cardiovasc Res, Repisalud, Instituto de Salud Carlos III (ISCIII)
Accession number :
edsair.doi.dedup.....e163be9a1b2dd354d5cf8b9e088f1626
Full Text :
https://doi.org/10.1093/cvr/cvaa117